Can we predict if patients with SLE will require more than one cycle of rituximab?

OBJECTIVE: To identify clinical and serological features that distinguish patients with SLE who require single as opposed to repeated rituximab (RTX) cycles. METHODS: All 175 SLE patients followed up at University College Hospital from 2000 onwards were retrospectively reviewed. They were divided in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández González, Raquel, Abida, Rym, Gisca, Eugeniu, Duarte, Leila, Isenberg, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071578/
https://www.ncbi.nlm.nih.gov/pubmed/34240116
http://dx.doi.org/10.1093/rheumatology/keab527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071578/
https://www.ncbi.nlm.nih.gov/pubmed/34240116
http://dx.doi.org/10.1093/rheumatology/keab527

Ejemplares similares